SUMMARY: Salmonella enterica serovar Typhimurium is a common cause of non-typhoid salmonellosis in humans. Since 2006, an increase in the human infections caused by U302 phage type in Slovakia has been documented and, from 2006 to 2011, a total of 291 U302 human strains were isolated. Antimicrobial susceptibility testing demonstrated that these strains had a high overall antimicrobial resistance and 244 (83.8z) of the tested strains were multidrug-resistant (MDR). The most prevalent resistance was to ampicillin, streptomycin, sulfisoxazole, and tetracycline (R-type ASSuT), which was verified in 87 (29.9z) strains. The annual rate of this resistance type varies, but the largest number of these strains were identified in 2009 and 2010. The classical pentaresistance phenotype (R-type ACSSuT), characteristic of the DT104 phage type, was found only in 40 (13.7z) U302 strains. These results suggested that although the prevalence of DT104 phage type has decreased, ASSuT as well as ACSSuT resistance markers continue to circulate. Therefore, continual surveillance of the occurrence of these and similar MDR phage types is necessary.
Salmonella is one of the most important pathogens in both humans and animals worldwide, as they cause gastrointestinal infections and septicemia. It comprises more than 2,600 serovars (1) with different host adaptations and degrees of virulence, and most are considered as potential human pathogens, although only a relatively small number of serovars have been associated with human infections. Among these, Salmonella enterica serovar Typhimurium is the second most frequent type of Salmonella serovar isolated from Slovakia.
For epidemiological purposes, differentiation of the strains of this serovar is essential and phage typing has been a useful phenotypic definitive method of choice in many countries for decades.
In 2006, the Slovak National Reference Centre for Salmonella phage typing (Slovak Medical University, Bratislava, Slovakia) for the first time identified a multidrug-resistant (MDR) U302 phage type among S. Typhimurium strains isolated from human infections. In recent years, MDR S. Typhimurium DT104, which usually has chromosomal-encoded pentaresistance against ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracyclines has spread internationally, and is now prevalent in Slovakia (2-4). Apart from causing severe illnesses, there are concerns regarding the emergence of MDR S. Typhimurium in various phage types as well as other serovars because of the reduction in the number of available treatment options, which can lead to treatment failure (5) .
In the present study, we assessed the prevalence of resistance to ampicillin, streptomycin, sulfonamide, and tetracycline (R-type ASSuT) in S. Typhimurium phage type U302 strains isolated from human cases from 2006 to 2011.
During this period, a total of 1,779 S.Typhimurium strains were isolated from sporadic human cases and sent to the National Reference Centre for Salmonella phage typing (Table 1) . Isolated strains were phage typed using phage preparations supplied by the Health Protection Agency (Colindale, London, UK) according to the methods of Anderson et al. (6) . On the basis of the phage typing results, phage type U302 strains were selected and isolated from feces, except for two strains isolated from urine and one from a purulent wound.
A total of 291 U302 strains were tested for antimicrobial susceptibility using the standard disk diffusion method according to the protocol of the Clinical and Laboratory Standards Institute (7) . Resistance against the following antimicrobial agents was assessed: ampicillin (10 mg), ceftriaxone (30 mg), chloramphenicol (30 mg), gentamicin (10 mg), ciprofloxacin (5 mg), sulfisoxazole (250 mg), tetracycline (30 mg), streptomycin (10 mg), trimethoprim (5 mg), trimethoprim-sulfamethoxazole (1.25/23.75 mg), and nalidixic acid (30 mg). Escherichia coli ATTC 25022 was used as the reference strain.
S. Typhimurium is the second most common serovar isolated from Slovakia, exceeded only by S. Enteritidis (8) . Subtyping of S. Typhimurium by phage typing is a well-established method and plays a vital role in the detection of outbreaks and identification of connection The most prevalent resistance types are indicated as bold letters. A, ampicillin; C, chloramphenicol; S, streptomycin; Su, sulfisoxazole; SxT, trimethoprimsulfamethoxazole; T, tetracycline; TMP, trimethoprim; NA, nalidixic acid.
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between seemingly sporadic cases. It also enables the monitoring of new phage types or phage types with new characteristics.
Here we report the emergence of the MDR U302 phage type, which was identified in the National Reference Centre for Salmonella phage typing for the first time in 2006. The distribution of a total of 291 human S. Table 1 . Although the number of U302 human strains in individual years differed among the total number of isolates, it was the most frequent phage type identified in 2007-2009. Since 1990, MDR S. Typhimurium DT104 has emerged as a worldwide health concern in humans and food animals. In Slovakia, this phage type was identified for the first time in 1997 and since then has become the most prevalent phage type (4).
Typhimurium isolates identified as U302 phage types during 2006-2011 is shown in
S. Typhimurium U302 is a phage type of epidemiological importance because of its multi-resistant character. Pritchett et al. (9) identified a DNA sequence unique to the DT104 and U302 phage types and confirmed a close relationship between them. Although U302 phage type strains were sporadically isolated in Slovakia, other infectious outbreaks caused by strains of this phage type have been reported. Ethelberg et al. (10) described a prolonged restaurant-associated outbreak in Denmark and neighboring countries during July and August 2003, which comprised 67 laboratory-confirmed cases; however, the actual number of patients was estimated to be more than 390. This particular strain was isolated from a buffet, which was probably contaminated by an assistant chef who was found to excrete the epidemic strain. Another widespread outbreak caused by the epidemic U302 strain involved 45 cases in southern Ontario (Canada) over a 3-month period in 2005. The most likely hypothesis supported by the findings of an epidemiologic investigation was that the illness was associated with salami, mortadella, and/or prosciutto made by a single producer (11) .
Antibiotic resistance dramatically increased in S. Typhimurium, which is characterized by an especially high incidence of MDR strains in Europe due to a clonal and international spread of phage type DT104 that was initially linked to cattle farms (2, 12) . The aim of this study was to examine the antimicrobial susceptibility of the human U302 phage type strains that belonged to the most frequent phage types in recent years. Among 291 isolates tested, 31 resistance profiles were identified ( Table 2) .
Among the tested strains, 47 (16.2z) were resistant against one or two antimicrobial agents and up to 244 (83.8z) were MDR. MDR Salmonella are of worldwide interest because they reduce the number of therapy options in human and veterinary medicine. The most prevalent resistance is to ampicillin, streptomycin, sulfisoxazole, and tetracycline (R-type ASSuT), which was identified in 87 isolates (29.9z) during 2006-2011. The aforementioned infectious outbreak described by Ethelberg et al. (10) was caused by a phage type U302 strain with the same resistance type. The annual rate of this resistance type varied, but the largest numbers were identified in 2009 and 2010. Although a close relationship between the DT104 and U302 phage types has been described, the characteristic pentaresistance of DT104 to ampicillin, chloramphenicol, streptomycin, sulfonamide, and tetracycline (R-type ACSSuT) was found only in 40 (13.7z) U302 strains. However, we did not investigate antibiotic resistance genes among the U302 tested strains. Walker et al. (13) demonstrated that the majority of MDR U302 strains possessed the same antibiotic resistance genes as MDR DT104. The ACSSuT resistance type predominantly belonged to phage types DT104, DT120, and DT20a (14-16), but Reis et al. (17) also found this resistance type in human DT193 phage type strains. An almost identical number of U302 strains (14.4z) in the present study belonged to the ASSu resistance type.
In the 1970s, various Salmonella outbreaks erupted in the United Kingdom and other European countries provoked by DT204, DT204c, and DT193, which exhibited multidrug resistance with the exception of the DT193 phage type, but they have not been recorded in Slovakia (5, 18, 19) .
The results of the present study confirmed that all of the tested S. Typhimurium U302 strains were susceptible to third-generation cephalosporin and fluoroquinolone, which should therefore be considered crucial components of therapy for Salmonella infections in humans. However, only 20 strains (6.9z) were resistant to nalidixic acid, which is a precursor to fluoroquinolones.
Apart from causing severe illnesses, there are concerns regarding the emergence of MDR Salmonella strains of various phage types because they are potential donors of resistance genes to other pathogens or commensals in the gastrointestinal tract (20, 21) . Furthermore, it is widely accepted that the development of MDR bacteria is promoted by the use of antimicrobial drugs in food animals (18) . Our results suggested that although there was a change in prevalent phage types, the MDR markers continued to circulate. Lastly, with regard to lysogenic conversion, there is need for continual surveillance of the occurrence of these and similar MDR phage types.
